Precision medicine is delivering measurable performance in value-based care, but the returns often lag the costs.
This whitepaper examines financing levers that can help healthcare executives and value-based care leaders advance the clinical and financial benefits of precision medicine. It details unique opportunities for leaders to drive solutions that strengthen contract performance and organizational resiliency, including:
- Receivables financing to accelerate liquidity from future performance payments.
- Risk underwriting tied to performance milestones or payer reimbursements to absorb volatility.
- Capitalization financing for ACOs, direct-to-employer arrangements, or provider-sponsored plans facing reserve requirements.
- Structured loan arrangements aligned with clinical implementation timelines and tied to expected contract performance improvements.
- Population-level investment pools that fund genomics, analytics platforms, or infrastructure shared across payer-provider entities.
- Healthcare finance leaders take a strategic approach to these challenges can better position their organization to capture measurable savings while improving outcomes.
Please fill out the form to download the whitepaper.